Home › Funds › MCDANIEL TERRY & CO › ABT

MCDANIEL TERRY & CO position in ABT

ABBOTT LABORATORIES · Health Care

MCDANIEL TERRY & CO reported holding 13,293 shares of ABT (ABBOTT LABORATORIES) in its Q3 2026 13F filing — a position valued at US$1.3M, representing 0.10% of its reported portfolio and ranking #44 among its reported holdings. MCDANIEL TERRY & CO has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)13.29K sh
Reported value held$1.31M
Portfolio Weight0.10%
First reportedQ3 2023
Last changeHold
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How MCDANIEL TERRY & CO's ABT position evolved

MCDANIEL TERRY & CO first disclosed a stake in ABT in Q3 2023 at 20,558 shares (US$2.0M). The position peaked in Q2 2025 at 18,206 shares, worth US$2.5M. Across 13 filings, MCDANIEL TERRY & CO increased the stake 1 time(s), trimmed it 5 time(s) and left it unchanged 6 time(s). The most recent filing (Q3 2026) shows 13,293 shares valued at US$1.3M. Notable position changes include a 32% trim in Q4 2025 (shares fell 18% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 20.56K $1.99M New
Q4 2023 19.65K $2.16M Reduce
Q1 2024 18.34K $2.08M Reduce
Q2 2024 18.30K $1.90M Hold
Q3 2024 18.17K $2.07M Reduce
Q4 2024 18.18K $2.06M Hold
Q1 2025 18.15K $2.41M Hold
Q2 2025 18.21K $2.48M Hold
Q3 2025 18.22K $2.44M Hold
Q4 2025 12.39K $1.55M Reduce
Q1 2026 13.40K $1.38M Add
Q2 2026 13.28K $1.21M Reduce
Q3 2026 13.29K $1.31M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABT and 13F data

ABT (ABBOTT LABORATORIES) is a Health Care company. 21 other funds we track also report a position in ABT — the largest reported positions include Vanguard Group (US$22.00B), Charles Schwab Investment Management (US$5.41B), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (US$5.41B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABT

All ABT fund holders →

FAQ

How long has MCDANIEL TERRY & CO held ABT?

MCDANIEL TERRY & CO has disclosed ABT holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is MCDANIEL TERRY & CO's current position in ABT?

As of Q3 2026, MCDANIEL TERRY & CO holds 13.29K shares of ABT (ABBOTT LABORATORIES), valued at $1.31M, representing 0.10% of its reported portfolio and ranking #44.

Has MCDANIEL TERRY & CO been buying or selling ABT?

In the latest 13F filing (Q3 2026), MCDANIEL TERRY & CO held unchanged its position in ABT. The position peaked in Q2 2025 at 18.21K shares.

Which other funds hold ABT?

Other major institutional holders of ABT include Vanguard Group, Charles Schwab Investment Management, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 21 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.